Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald D Alvarez

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
Gynecologic Oncology Reports|April 15, 2021
Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fairLaura M Chambers, Catherine H Watson, Meng Yao, et al.
Gynecologic Oncology|January 22, 2005
Immune responses to human papillomavirus in genital tract of women with cervical cancerHuan H Nguyen, Thomas R Broker, Louise T Chow, et al.
Gynecologic Oncology|February 21, 2006
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancerJacob M Estes, Charles A Leath, Sybilann Williams, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 6, 2011
A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasiaChandrika J Piyathilake, Maurizio Macaluso, Ronald D Alvarez, et al.
The Oncologist|April 15, 2006
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patientsRodney P Rocconi, J Michael Straughn, Charles A Leath, et al.
American Journal of Obstetrics and Gynecology|June 1, 2025
Addressing the crisis in women's health research: an American Gynecological and Obstetrical Society statementMostafa A Borahay, Marianna Alperin, David Turok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Stem cell pathways contribute to clinical chemoresistance in ovarian cancerAdam D Steg, Kerri S Bevis, Ashwini A Katre, et al.
Gynecologic Oncology|September 24, 2004
The impact of aborted radical hysterectomy in patients with cervical carcinomaCharles A Leath, J Michael Straughn, Jacob M Estes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancerYuko Tsuruta, Larisa Pereboeva, Martina Breidenbach, et al.
Gynecologic Oncology|December 19, 2006
Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)Rodney P Rocconi, Zeng B Zhu, Mariam Stoff-Khalili, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
Gynecologic Oncology Reports|April 15, 2021
Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fairLaura M Chambers, Catherine H Watson, Meng Yao, et al.
Gynecologic Oncology|January 22, 2005
Immune responses to human papillomavirus in genital tract of women with cervical cancerHuan H Nguyen, Thomas R Broker, Louise T Chow, et al.
Gynecologic Oncology|February 21, 2006
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancerJacob M Estes, Charles A Leath, Sybilann Williams, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 6, 2011
A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasiaChandrika J Piyathilake, Maurizio Macaluso, Ronald D Alvarez, et al.
The Oncologist|April 15, 2006
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patientsRodney P Rocconi, J Michael Straughn, Charles A Leath, et al.
American Journal of Obstetrics and Gynecology|June 1, 2025
Addressing the crisis in women's health research: an American Gynecological and Obstetrical Society statementMostafa A Borahay, Marianna Alperin, David Turok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Stem cell pathways contribute to clinical chemoresistance in ovarian cancerAdam D Steg, Kerri S Bevis, Ashwini A Katre, et al.
Gynecologic Oncology|September 24, 2004
The impact of aborted radical hysterectomy in patients with cervical carcinomaCharles A Leath, J Michael Straughn, Jacob M Estes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancerYuko Tsuruta, Larisa Pereboeva, Martina Breidenbach, et al.
Gynecologic Oncology|December 19, 2006
Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)Rodney P Rocconi, Zeng B Zhu, Mariam Stoff-Khalili, et al.
Pageof 22